EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TongGuanWan Alleviates Doxorubicin- and Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis by Modulating Apoptotic and Fibrotic Pathways

Jung-Joo Yoon, Ai-Lin Tai, Hye-Yoom Kim iD, Byung-Hyuk Han, Sarah Shin iD, Ho-Sub Lee, Dae-Gill Kang

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms251910573 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Jung-Joo Yoon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hanbang Cardio-Renal Syndrome Research Center, Wonkwang University, 460, Iksan-daero, Iksan 54538, Republic of Korea. Hauptthemen laut MEDLINE: Isoproterenol, Doxorubicin, Fibrosis, Cardiomegaly. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure, a major public health issue, often stems from prolonged stress or damage to the heart muscle, leading to cardiac hypertrophy. This can progress to heart failure and other cardiovascular problems. Doxorubicin (DOX), a common chemotherapy drug, and isoproterenol (ISO), a β-adrenergic agonist, both induce cardiac hypertrophy through different mechanisms. This study investigates TongGuanWan (TGW,), a traditional herbal remedy, for its effects on cardiac hypertrophy and fibrosis in DOX-induced H9c2 cells and ISO-induced mouse models. TGW was found to counteract DOX-induced increases in H9c2 cell surface area (n = 8, p < 0.01) and improve biomarkers like ANP (n = 3, p < 0.01)) and BNP (n = 3, p < 0.01). It inhibited the MAPK pathway (n = 4, p < 0.01) and GATA-4/calcineurin/NFAT-3 signaling, reduced inflammation by decreasing NF-κB p65 translocation, and enhanced apoptosis-related factors such as caspase-3 (n = 3, p < 0.01), caspase-9 (n = 3, p < 0.01), Bax (n = 3, p < 0.01), and Bcl-2 (n = 3, p < 0.01). Flow cytometry showed TGW reduced apoptotic cell populations. In vivo, TGW reduced heart (n = 8~10, p < 0.01), and left ventricle weights (n = 6~7), cardiac hypertrophy markers (n = 3, p < 0.01), and perivascular fibrosis in ISO-induced mice, with Western blot analysis confirming decreased levels of fibrosis-related factors like fibronectin, α-SMA (n = 3, p < 0.05), and collagen type I (n = 3, p < 0.05). These findings suggest TGW has potential as a therapeutic option for cardiac hypertrophy and fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsoproterenolDoxorubicinFibrosisCardiomegalyApoptosisDrugs, Chinese HerbalAnimalsMiceMaleCell LineRatsSignal TransductionMyocytes, CardiacDisease Models, Animal

Stichwörter der Autor:innen

TongGuanWanapoptosiscardiac hypertrophydoxorubicinfibrosisheart failure

Substanzen

IsoproterenolDoxorubicinDrugs, Chinese Herbal

Autor:innen und Institutionen

  • Hanbang Cardio-Renal Syndrome Research Center, Wonkwang University, 460, Iksan-daero, Iksan 54538, Republic of Korea.
  • College of Oriental Medicine and Professional Graduate School of Oriental Medicine, Wonkwang University, 460, Iksan-daero, Iksan 54538, Republic of Korea.
  • KM Science Research Division, Korea Institute of Oriental Medicine, 1672, Yuseong-daero, Yuseong-gu, Daejeon 34054, Republic of Korea.

ORCID-Profile: Hye-Yoom Kim, Sarah Shin

Förderung

  • the National Research Foundation of Korea

Zitieren

APA

Yoon, J. J., Tai, A. L., Kim, H. Y., Han, B. H., Shin, S., Lee, H. S., & Kang, D. G. (2024). TongGuanWan Alleviates Doxorubicin- and Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis by Modulating Apoptotic and Fibrotic Pathways. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910573

Vancouver

Yoon JJ, Tai AL, Kim HY, Han BH, Shin S, Lee HS, et al. TongGuanWan Alleviates Doxorubicin- and Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis by Modulating Apoptotic and Fibrotic Pathways. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910573

BibTeX
@article{Yoon2024,
  author = {Yoon, Jung-Joo and Tai, Ai-Lin and Kim, Hye-Yoom and Han, Byung-Hyuk and Shin, Sarah and Lee, Ho-Sub and Kang, Dae-Gill},
  title = {TongGuanWan Alleviates Doxorubicin- and Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis by Modulating Apoptotic and Fibrotic Pathways},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms251910573}
}
Kostenlos starten →